G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2002
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002069899A3 Methods and compositions for the treatment and prevention of smooth muscle cell proliferation
12/19/2002	WO2002068603A3 Materials and methods for the induction of premature chromosome condensation
12/19/2002	WO2002068462A3 Internal standard for electrophoretic and chromatographic separation processes
12/19/2002	WO2002066682A3 Rat toxicologically relevant genes and uses thereof
12/19/2002	WO2002058626A9 Methods and compositions for the identification and treatment of neurodegenerative disorders
12/19/2002	WO2002057787A3 Detection of survivin in the biological fluids of cancer patients
12/19/2002	WO2002054060A3 Device for analyzing gas
12/19/2002	WO2002048334A3 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof
12/19/2002	WO2002040994A3 System and method for assaying drugs
12/19/2002	WO2002021135A3 Rapid screen to identify p-glycoprotein substrates and high-affinity modulators
12/19/2002	WO2002015779A3 Method and apparatus for determining blood oxygen transport
12/19/2002	WO2002012854A3 Systems and methods for providing information concerning chromophores in physiological media
12/19/2002	WO2002012338A3 Screening method
12/19/2002	WO2002011767A3 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
12/19/2002	WO2002010753A3 Autoimmunity to angiotensin at1 receptors in schizophrenia
12/19/2002	WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses
12/19/2002	WO2002004665A3 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors
12/19/2002	WO2001079850A3 Method and apparatus for selective biological material detection
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001075450A9 Fluorescent lifetime assays for non-invasive quantification of analytes
12/19/2002	WO2001075446A9 Device and method for cytology slide preparation
12/19/2002	WO2001073443A9 Methods and compositions for the simultaneous detection of multiple analytes
12/19/2002	WO2001072977A9 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
12/19/2002	WO2001071350A9 Methods of registering trans-membrane electric potentials
12/19/2002	WO2001071345A9 Optically and fluidically enhanced in vitro diagnostic test chamber
12/19/2002	WO2001067112A3 Automaton for biological analysis
12/19/2002	WO2001066795A8 Method for analysing the length of a nucleic acid molecule
12/19/2002	WO2000058303A9 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
12/19/2002	US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/19/2002	US20020194631 Method of treating psoriasis using anti-interleukin 12 antibody
12/19/2002	US20020194628 Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof
12/19/2002	US20020194624 Methods for screening and identifying host pathogen defense genes
12/19/2002	US20020193956 Method and device for determining the color appearance of color overprints
12/19/2002	US20020193951 Leakage inspection method for sealed container and apparatus for carrying out the method
12/19/2002	US20020193949 Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
12/19/2002	US20020193912 Method and apparatus for measuring energy consumed during plastic deformation in multi-ply board systems
12/19/2002	US20020193698 Method and measuring equipment for measuring nitric oxide concentration in exhaled air
12/19/2002	US20020193672 Long wave fluorophore sensor compounds and other fluorescent sensor compounds in polymers
12/19/2002	US20020193586 Polysaccharide conjugates of biomolecules
12/19/2002	US20020193584 Endogenous and non-endogenous versions of human G protein-coupled receptors
12/19/2002	US20020193575 Fusion protein for use in the treatment of allergies
12/19/2002	US20020193572 Generation of glycosylated antibody; obtain cell, incubate with vector expressing preferential antibody, transfected with a vector, propagate, express vector, recover antibody
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193563 Randomly generated glycopeptide combinatorial libraries
12/19/2002	US20020193436 Inhibit digestion by terminating or blocking synthesis of digestive enzymes by activating trypsin modulating oostatic factor receptor
12/19/2002	US20020193412 Compounds and compositions for treating tissue ischemia
12/19/2002	US20020193374 Administering to subject having cytomegalo viurs (CMV), an image-generating benzamide compound for diagnosing CMV
12/19/2002	US20020193364 For therapy of central nervous system (CNS) diseases
12/19/2002	US20020193326 Methods of inhibiting proliferative diseases
12/19/2002	US20020193317 Using smilagenin, prazerigenin, an astragaloside, tigogenin, ruscogenin, hecogenin and diosgenin in manufacture of medicament for therayp of condition characterised by deficiency in postsynaptic membrane-bound receptor number
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193304 Anti-HIV agents
12/19/2002	US20020193303 58860, a human cholesteryl ester hydrolase and uses therefor
12/19/2002	US20020193300 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020193299 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/19/2002	US20020193295 Immunogenic peptides and uses thereof
12/19/2002	US20020193291 Treating NIDDM with RXR agonists
12/19/2002	US20020193288 Methods of treating hypertension and compositions for use therein
12/19/2002	US20020192843 Nano-scaled dendrimer-based colorimetric biosensors
12/19/2002	US20020192841 Apparatus for use the detection of preferential biopolymers in sample
12/19/2002	US20020192840 Isolating preferential target particle in solution; obtain sample, incubate with binding particles, detet signal, recover particles
12/19/2002	US20020192839 Collection device for single step assay of oral fluids
12/19/2002	US20020192838 Ddetermining pregnancy in animals; obtain animal, monitor expression of pregnancy induced protein, monitor mating of animal, determine amplification in concentration of pregnancy induced protein, amplified concentration indicates pregnancy
12/19/2002	US20020192835 Immunochromatographic assay strip and assay device having transparent plastic backing and method for producing the same
12/19/2002	US20020192833 Method and apparatus for detecting the presence of a fluid on a test strip
12/19/2002	US20020192821 Increased functional activity and/or expression of ABC transporters protects against the loss of dopamine neurons associated with Parkinson's disease
12/19/2002	US20020192807 Analyte measurement device and method of use
12/19/2002	US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002	US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002	US20020192789 Novel enterokinase cleavage sequences
12/19/2002	US20020192785 For use in therapeutics, diagnostics, and as research tools
12/19/2002	US20020192781 Desaturase antigen of mycobacterium tuberculosis
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192757 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
12/19/2002	US20020192755 Generation of preferential protein in genetically engineered cell; obtain genetically engineeredd cell, express vector, recover protein
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192740 Mixing a bacterium having the type III secretory mechanism and an erythrocyte suspension, adding the type III secretory mechanism inhibitor thereto, and detecting changes in the thus formed hemolytic activity
12/19/2002	US20020192738 Detection of tyrosinase in cell or tissue sample; obtain sample, incubate wit tyrosinase substrate, detect signal, presence of signal indicates presence of tyrosinase
12/19/2002	US20020192737 Detecting modulators of oxidoreductases; obtain sample, incubate with modulator, detect signal, monitor adjustment in enzyme activity
12/19/2002	US20020192735 Analysis of protein in sample; obtain liquid sample, incubate with tripsin, ionize mixture, analyze gas phase, evaluate protein structure
12/19/2002	US20020192734 Used as an additive in a tube to neutralize residual heparin in specimens taken from heparinized patients and accelerate clotting; irradiation stable; for minimizing interference from heparin in a blood sample
12/19/2002	US20020192733 Reagent test strip for analyte determination having a hemolyzing agent
12/19/2002	US20020192731 Disinfecting medical instruments; obtain instruments, heat, expose to enzymes, recover instruments
12/19/2002	US20020192730 Monitoring therapies for vision defects, psoriasis, cancer, rheumatoid arthritis, atherosclerosis and kaposi's sarcoma; obtain cells, incubate with antiproliferative agents, monitor concentration of progenitor cells, compare to control
12/19/2002	US20020192728 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/19/2002	US20020192727 MAP-2 as a determinant of metastatic potential
12/19/2002	US20020192723 Protein for use in the diagnosis and treatment of autoimmune disease
12/19/2002	US20020192722 Biosensor surface for use in he detection of preferential particles in sample
12/19/2002	US20020192721 Modular molecular clasps and uses thereof
12/19/2002	US20020192720 Detection of preferential proteins in sample, obtain sample, incubate with probe, detect signal, detect the difference in the expression of proteins in samples
12/19/2002	US20020192719 Detecting preferential particles on solid support; generate solid support, incubate with sample, detect signal, monitor fluorescence
12/19/2002	US20020192718 Substrate preparation for chemical-species-specific binding
12/19/2002	US20020192717 Detecting preferential particle in sample; obtain cells, incubate with sample, detect signal in cell
12/19/2002	US20020192715 Test kit for determining process for determining antibiotics containing a beta-lactam ring in a biological fluid
12/19/2002	US20020192713 Diagnosis of parasitic infections; obtain sample, incubate with antibody, detect signal, presence of signal indicates infections
12/19/2002	US20020192712 Method and reagent for testing for multiple organ failure in sirs by cytochrome C measurement
12/19/2002	US20020192711 Methods for identifying ligands of G-Protein-Coupled receptors
12/19/2002	US20020192710 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms

1 ... 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 ... 3937